Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Lymphoma
>>
Takeda
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
Ninlaro
(ixazomib) / Takeda
Iclusig
(ponatinib) / Takeda, Otsuka, Incyte
pevonedistat
(MLN4924) / Takeda
Taltorvic
(ridaforolimus) / Takeda, Merck (MSD)
Alunbrig
(brigatinib) / Takeda
Zejula
(niraparib) / GSK, J&J
ganitumab
(AMG 479) / Takeda, ImmunityBio